WuXi Biologics Named to the Hang Seng Corporate Sustainability Benchmark Index

Recognized for WuXi Biologics’ outstanding performance and commitment to sustainability and environmental, social, and governance (ESG) excellence. WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced its inclusion in the 2025 Hang Seng Corporate…










